News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Wegovy should be used in conjunction with healthy lifestyle shifts, including diet and regular exercise. Wegovy vs. Ozempic. ... so check your specific plan information.
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.
A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.
They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...